Discover the complete record of transactions filed by Lee Christopher G, Directeur Scientifique. Officer active across 1 companies, notably Apria, Inc.. Aggregated, 13 filings have been recorded. Total volume traded: €140k. The latest transaction was disclosed on 10 March 2022 — Attribution. Regulator: SEC (Form 4). The full history is accessible without signup.
Ruben Tommasi serves as Chief Scientific Officer at Entasis Therapeutics Holdings Inc. In this role, he is responsible for leading the company's research and development activities. Ruben plays a key role in innovation and the development of new therapies to meet patient needs.